Everything You’ve Wanted to Know About MS But Were Afraid to Ask

RELEASE DATE: June 30, 2020 EXPIRATION DATE: June 30, 2021 This series of videos is a comprehensive online curriculum that provides evidence-based, expert-directed overviews of topics related to the multidisciplinary management of multiple sclerosis (MS). Our expert faculty share their knowledge and insights with the goal of improving application of the latest evidence related to […]

Advanced Therapeutic Strategies and Family Planning for Women with Multiple Sclerosis

RELEASE DATE: June 25, 2020 EXPIRATION DATE: June 24, 2021 Program Overview This program is derived from content presented at the Consortium of Multiple Sclerosis Centers (CMSC) 34th Annual Meeting. This CME/CE activity will highlight advanced therapeutic strategies and family planning best practices for women with multiple sclerosis (MS). The expert faculty, led by Dr. Fred […]

Journal Club: The COVID-19 Pandemic and the Use of MS Disease Modifying Therapies

Release Date: July 8, 2020 Valid for Credit Through: July 31, 2021 SERIES TITLE Advanced Perspectives in MS: A Virtual Journal Club Series for the Multiple Sclerosis Clinician ARTICLE TITLE The COVID-19 Pandemic and the Use of MS Disease Modifying Therapies TARGET AUDIENCE This activity has been designed to meet the educational needs of physicians, […]

Telemedicine in the Era of COVID-19: Mitigating Risk for People Living with Multiple Sclerosis

LIVE WEBINAR ONWednesday, July 22, 20207:00 – 8:30 pm EDT Click here to view the flyer PROGRAM AGENDA 7:00 pm Opening RemarksEdward J. Fox, MD, PhD, Chairperson COVID-19 ExperienceStephanie Agrella, PhDc, MSN, RN, ANP-BC, MSCNJoseph R. Berger, MD, FACP, FAAN, FANAFrederick W. Foley, PhDEdward J. Fox, MD, PhD COVID-19 and Risk in People Living with […]

A Virtual Reality View: Selecting Disease-Modifying Therapy for Multiple Sclerosis: Tools to Achieve and Maintain Control of a Dynamic Disease

RELEASE DATE: June 16, 2020 EXPIRATION DATE: June 16, 2021 FACULTY Patricia K. Coyle, MD, FAAN, FANA Professor and Interim Chair Director, MS Comprehensive Care Center Stony Brook University Medical Center Stony Brook, New York PROGRAM OVERVIEW This activity will cover the treatment and management of patients with multiple sclerosis (MS). TARGET AUDIENCE This activity is designed […]

The Role of Neurologists and Neuroophthalmologists in the Diagnosis and Management of Neuromyelitis Optica Spectrum Disorder

RELEASE DATE: June 16, 2020 EXPIRATION DATE: June 16, 2021 FACULTY Brian G. Weinshenker, MD, FRCP(C) Consultant, Department of Neurology Professor of Neurology, College of Medicine Mayo Clinic Rochester, MN PROGRAM OVERVIEW This case-based activity will cover the treatment and management of patients with NMOSD. TARGET AUDIENCE This activity is designed to meet the educational needs of […]

Journal Club: The COVID-19 Pandemic and the Use of MS Disease Modifying Therapies

Wednesday, June 24, 2020 7:00 pm (ET) SERIES TITLE Advanced Perspectives in MS: A Virtual Journal Club Series for the Multiple Sclerosis Clinician ARTICLE TITLE The COVID-19 Pandemic and the Use of MS Disease Modifying Therapies TARGET AUDIENCE This activity has been designed to meet the educational needs of physicians, PAs, nursing professionals, and other […]

Novel BTK Inhibitors: Effects on Adaptive and Innate Immunity in Multiple Sclerosis

Thursday, June 25th, 2020 7:00 – 8:30 pm (ET) AGENDA I. Why We Need New Approaches to Treating MS – Fred D. Lublin, MD II. The Science of BTK Inhibitors: Adaptive and Innate Immunity – Benjamin M. Greenberg, MD, MHS III. A Clinical Trial Review and Analysis on the Safety and Efficacy of Novel BTK […]

The Iceberg Effect: Subclinical Disease Activity in Multiple Sclerosis

RELEASE DATE: June 1, 2020 EXPIRATION DATE: June 1, 2021 TARGET AUDIENCEThis activity is designed to meet the educational needs of physicians, nurses, advanced practice clinicians, and pharmacists who manage patients with multiple sclerosis (MS). PROGRAM DESCRIPTIONAsymptomatic or subclinical progression occurs in all stages of multiple sclerosis (MS) and should be part of treatment decisions, especially in […]

IJMSC: Clinically Assessed Walking Capacity Versus Real-World Walking Performance in People with Multiple Sclerosis

RELEASE DATE: June 1, 2020 EXPIRATION DATE: June 1, 2021 TARGET AUDIENCEThe target audience for this activity is physicians, physician assistants, nursing professionals, and other health care providers involved in the management of patients with multiple sclerosis (MS). LEARNING OBJECTIVES Differentiate between measurement tools for clinical walking capacity and for real-world performance. Describe discrepancies between performance on […]